Follow-up study at four years after the end of clinical trial on the efficacy and safety of total glucosides of peony in the treatment of primary sjogren’s syndrome

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022781

Enrollment

Unknown

Registered

2019-04-25

Start date

2019-05-01

Completion date

Unknown

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren's Syndrome

Interventions

Case series:TGP capsules

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1)Diagnosed with pSS according to the 2002 American-European Consensus Group international classification criteria for pSS; (2)Age over 18 years old.

Exclusion criteria

Exclusion criteria: Patients unable to sign written informed consent form.

Design outcomes

Primary

Measure	Time frame
ESSPRI;	—

Secondary

Measure	Time frame
ESSDAI;Patient global assessment (PGA);Dry mouth VAS score;Dry eye VAS score;Schirmer test;salivary flow rate;Immunoglobulin;erythrocyte sedimentation rate;C-reactive protein;Complement;	—

Countries

China

Contacts

Public ContactLi Xiaomei

Department of Rheumatology and Immunology, The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

lixiaomei@ustc.edu.cn+86 13866795533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026